Nishinomiya, Japan

Shoko Nakazato

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shoko Nakazato. Retrieved from https://idiyas.com/inventor/shoko-nakazato

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 53(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Shoko Nakazato: A Visionary Inventor Shaping the Future of Technology

Introduction:

Shoko Nakazato, a visionary inventor hailing from Nishinomiya, Japan, has made significant contributions to the world of technology. His relentless pursuit of innovation has earned him recognition as a trailblazer in the field.

Latest Patents:

Shoko Nakazato holds one patent for Oxazole compounds as prostaglandin E2 agonists or antagonists. These compounds, with their unique formula and properties, have proven to be valuable in the realm of medicament.

Career Highlights:

Working at Fujisawa Pharmaceutical Company, Ltd., Shoko Nakazato has demonstrated a keen understanding of pharmaceutical research and development. His expertise in the field has led to pioneering discoveries that have advanced medical science.

Collaborations:

Throughout his career, Shoko Nakazato has collaborated with esteemed colleagues such as Kouji Hattori and Akira Tanaka. Together, they have engaged in groundbreaking research projects that have pushed the boundaries of innovation in the pharmaceutical industry.

Conclusion:

Shoko Nakazato's legacy as a visionary inventor is exemplified by his unwavering dedication to pushing the boundaries of technological advancement. His innovative spirit continues to inspire future generations of inventors and shape the landscape of innovation for years to come.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…